HEADER TRANSCRIPTION 05-JAN-15 4XHD
TITLE STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING DOMAIN WITH
TITLE 2 COMPOUND-1
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 2;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: ORPHAN NUCLEAR RECEPTOR PAR1,ORPHAN NUCLEAR RECEPTOR PXR,
COMPND 5 PREGNANE X RECEPTOR,STEROID AND XENOBIOTIC RECEPTOR,SXR;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: NR1I2, PXR;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PCO7
KEYWDS PREGNANE X RECEPTOR, PXR, LIGAND BINDING DOMAIN, STEROID RECEPTOR
KEYWDS 2 COACTIVATOR-1; CCR1, CHEMOKINE RECEPTOR-1; ADNECTIN NR, NUCLEAR
KEYWDS 3 RECEPTOR; AF, ACTIVATION FUNCTION; CYP, CYTOCHROME P450; MDR1,
KEYWDS 4 MULTI-DRUG RESISTANCE GENE-1., TRANSCRIPTION
EXPDTA X-RAY DIFFRACTION
AUTHOR J.A.KHAN,D.M.CAMAC
REVDAT 4 28-FEB-24 4XHD 1 JRNL REMARK
REVDAT 3 30-SEP-15 4XHD 1 JRNL
REVDAT 2 25-FEB-15 4XHD 1 JRNL
REVDAT 1 28-JAN-15 4XHD 0
JRNL AUTH J.A.KHAN,D.M.CAMAC,S.LOW,A.J.TEBBEN,D.L.WENSEL,M.C.WRIGHT,
JRNL AUTH 2 J.SU,V.JENNY,R.D.GUPTA,M.RUZANOV,K.A.RUSSO,A.BELL,Y.AN,
JRNL AUTH 3 J.W.BRYSON,M.GAO,P.GAMBHIRE,E.T.BALDWIN,D.GARDNER,
JRNL AUTH 4 C.L.CAVALLARO,J.V.DUNCIA,J.HYNES
JRNL TITL DEVELOPING ADNECTINS THAT TARGET SRC CO-ACTIVATOR BINDING TO
JRNL TITL 2 PXR: A STRUCTURAL APPROACH TOWARD UNDERSTANDING PROMISCUITY
JRNL TITL 3 OF PXR.
JRNL REF J.MOL.BIOL. V. 427 924 2015
JRNL REFN ESSN 1089-8638
JRNL PMID 25579995
JRNL DOI 10.1016/J.JMB.2014.12.022
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH D.S.GARDNER,J.B.SANTELLA,J.V.DUNCIA,P.H.CARTER,T.G.DHAR,
REMARK 1 AUTH 2 H.WU,W.GUO,C.CAVALLARO,K.VAN KIRK,M.YARDE,S.W.BRICENO,
REMARK 1 AUTH 3 R.R.GRAFSTROM,R.LIU,S.R.PATEL,A.J.TEBBEN,D.CAMAC,J.KHAN,
REMARK 1 AUTH 4 A.WATSON,G.YANG,A.ROSE,W.R.FOSTER,M.E.CVIJIC,P.DAVIES,
REMARK 1 AUTH 5 J.HYNES
REMARK 1 TITL THE DISCOVERY OF BMS-457, A POTENT AND SELECTIVE CCR1
REMARK 1 TITL 2 ANTAGONIST.
REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 23 3833 2013
REMARK 1 REFN ESSN 1464-3405
REMARK 1 PMID 23707259
REMARK 1 DOI 10.1016/J.BMCL.2013.04.079
REMARK 2
REMARK 2 RESOLUTION. 2.40 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.2
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.74
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3
REMARK 3 NUMBER OF REFLECTIONS : 14643
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.200
REMARK 3 R VALUE (WORKING SET) : 0.198
REMARK 3 FREE R VALUE : 0.242
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030
REMARK 3 FREE R VALUE TEST SET COUNT : 737
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 7
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.59
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.34
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2944
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2208
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2775
REMARK 3 BIN R VALUE (WORKING SET) : 0.2190
REMARK 3 BIN FREE R VALUE : 0.2511
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.74
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 169
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2176
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 35
REMARK 3 SOLVENT ATOMS : 68
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 49.61
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.08
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -1.36110
REMARK 3 B22 (A**2) : -1.36110
REMARK 3 B33 (A**2) : 2.72220
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.291
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.321
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.231
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.304
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.228
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.939
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.918
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 2265 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 3056 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 818 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 55 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 329 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 2265 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 283 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 2674 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.07
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.68
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.80
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 4XHD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-JAN-15.
REMARK 100 THE DEPOSITION ID IS D_1000205689.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 07-APR-08
REMARK 200 TEMPERATURE (KELVIN) : 100.0
REMARK 200 PH : 7.8
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-BM
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14661
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3
REMARK 200 DATA REDUNDANCY : 10.40
REMARK 200 R MERGE (I) : 0.10100
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 20.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9
REMARK 200 DATA REDUNDANCY IN SHELL : 10.60
REMARK 200 R MERGE FOR SHELL (I) : 0.68500
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.400
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.22
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M IMIDAZOLE PH 7.8, 8
REMARK 280 -10%(V/V)ISOPROPANOL. APO CRYSTAL WAS SOAKED WITH 5 MM COMPOUND
REMARK 280 1 AND CRYSTALS HARVESTED NEXT DAY USING 32% ETHYLENE GLYCOL AS
REMARK 280 CRYOPROTECTANT, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4
REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4
REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4
REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4
REMARK 290 7555 Y,X,-Z
REMARK 290 8555 -Y,-X,-Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 42.78200
REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 45.73800
REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 45.73800
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 64.17300
REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 45.73800
REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 45.73800
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 21.39100
REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 45.73800
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 45.73800
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 64.17300
REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 45.73800
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 45.73800
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 21.39100
REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 42.78200
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 300 REMARK: CHAINS A
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 2480 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 25810 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 0.00000
REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -42.78200
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 120
REMARK 465 LYS A 121
REMARK 465 LYS A 122
REMARK 465 HIS A 123
REMARK 465 HIS A 124
REMARK 465 HIS A 125
REMARK 465 HIS A 126
REMARK 465 HIS A 127
REMARK 465 HIS A 128
REMARK 465 GLY A 129
REMARK 465 SER A 130
REMARK 465 GLU A 131
REMARK 465 ARG A 132
REMARK 465 THR A 133
REMARK 465 GLY A 134
REMARK 465 THR A 135
REMARK 465 GLN A 136
REMARK 465 PRO A 137
REMARK 465 LEU A 138
REMARK 465 GLY A 139
REMARK 465 VAL A 140
REMARK 465 GLN A 141
REMARK 465 SER A 179
REMARK 465 SER A 180
REMARK 465 GLY A 181
REMARK 465 CYS A 182
REMARK 465 GLU A 183
REMARK 465 LEU A 184
REMARK 465 PRO A 185
REMARK 465 GLU A 186
REMARK 465 SER A 187
REMARK 465 LEU A 188
REMARK 465 GLN A 189
REMARK 465 ALA A 190
REMARK 465 PRO A 191
REMARK 465 SER A 192
REMARK 465 ARG A 193
REMARK 465 GLU A 194
REMARK 465 GLU A 195
REMARK 465 ALA A 196
REMARK 465 ASP A 310
REMARK 465 THR A 311
REMARK 465 ALA A 312
REMARK 465 GLY A 313
REMARK 465 THR A 432
REMARK 465 GLY A 433
REMARK 465 SER A 434
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LYS A 170 CE NZ
REMARK 470 LYS A 210 CE NZ
REMARK 470 HIS A 359 CG ND1 CD2 CE1 NE2
REMARK 470 ARG A 360 CD NE CZ NH1 NH2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 GLY A 233 N - CA - C ANGL. DEV. = 38.0 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 231 50.42 -143.73
REMARK 500 GLU A 235 -30.83 -38.35
REMARK 500 CYS A 301 65.49 -102.46
REMARK 500 PHE A 315 -113.99 67.41
REMARK 500 PHE A 349 59.15 -92.58
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS
REMARK 500
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH
REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED
REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.
REMARK 500 MODEL OMEGA
REMARK 500 SER A 231 GLY A 232 -115.97
REMARK 500 GLY A 232 GLY A 233 118.01
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 40U A 502
DBREF 4XHD A 130 434 UNP O75469 NR1I2_HUMAN 153 457
SEQADV 4XHD MET A 120 UNP O75469 INITIATING METHIONINE
SEQADV 4XHD LYS A 121 UNP O75469 EXPRESSION TAG
SEQADV 4XHD LYS A 122 UNP O75469 EXPRESSION TAG
SEQADV 4XHD HIS A 123 UNP O75469 EXPRESSION TAG
SEQADV 4XHD HIS A 124 UNP O75469 EXPRESSION TAG
SEQADV 4XHD HIS A 125 UNP O75469 EXPRESSION TAG
SEQADV 4XHD HIS A 126 UNP O75469 EXPRESSION TAG
SEQADV 4XHD HIS A 127 UNP O75469 EXPRESSION TAG
SEQADV 4XHD HIS A 128 UNP O75469 EXPRESSION TAG
SEQADV 4XHD GLY A 129 UNP O75469 EXPRESSION TAG
SEQRES 1 A 315 MET LYS LYS HIS HIS HIS HIS HIS HIS GLY SER GLU ARG
SEQRES 2 A 315 THR GLY THR GLN PRO LEU GLY VAL GLN GLY LEU THR GLU
SEQRES 3 A 315 GLU GLN ARG MET MET ILE ARG GLU LEU MET ASP ALA GLN
SEQRES 4 A 315 MET LYS THR PHE ASP THR THR PHE SER HIS PHE LYS ASN
SEQRES 5 A 315 PHE ARG LEU PRO GLY VAL LEU SER SER GLY CYS GLU LEU
SEQRES 6 A 315 PRO GLU SER LEU GLN ALA PRO SER ARG GLU GLU ALA ALA
SEQRES 7 A 315 LYS TRP SER GLN VAL ARG LYS ASP LEU CYS SER LEU LYS
SEQRES 8 A 315 VAL SER LEU GLN LEU ARG GLY GLU ASP GLY SER VAL TRP
SEQRES 9 A 315 ASN TYR LYS PRO PRO ALA ASP SER GLY GLY LYS GLU ILE
SEQRES 10 A 315 PHE SER LEU LEU PRO HIS MET ALA ASP MET SER THR TYR
SEQRES 11 A 315 MET PHE LYS GLY ILE ILE SER PHE ALA LYS VAL ILE SER
SEQRES 12 A 315 TYR PHE ARG ASP LEU PRO ILE GLU ASP GLN ILE SER LEU
SEQRES 13 A 315 LEU LYS GLY ALA ALA PHE GLU LEU CYS GLN LEU ARG PHE
SEQRES 14 A 315 ASN THR VAL PHE ASN ALA GLU THR GLY THR TRP GLU CYS
SEQRES 15 A 315 GLY ARG LEU SER TYR CYS LEU GLU ASP THR ALA GLY GLY
SEQRES 16 A 315 PHE GLN GLN LEU LEU LEU GLU PRO MET LEU LYS PHE HIS
SEQRES 17 A 315 TYR MET LEU LYS LYS LEU GLN LEU HIS GLU GLU GLU TYR
SEQRES 18 A 315 VAL LEU MET GLN ALA ILE SER LEU PHE SER PRO ASP ARG
SEQRES 19 A 315 PRO GLY VAL LEU GLN HIS ARG VAL VAL ASP GLN LEU GLN
SEQRES 20 A 315 GLU GLN PHE ALA ILE THR LEU LYS SER TYR ILE GLU CYS
SEQRES 21 A 315 ASN ARG PRO GLN PRO ALA HIS ARG PHE LEU PHE LEU LYS
SEQRES 22 A 315 ILE MET ALA MET LEU THR GLU LEU ARG SER ILE ASN ALA
SEQRES 23 A 315 GLN HIS THR GLN ARG LEU LEU ARG ILE GLN ASP ILE HIS
SEQRES 24 A 315 PRO PHE ALA THR PRO LEU MET GLN GLU LEU PHE GLY ILE
SEQRES 25 A 315 THR GLY SER
HET GOL A 501 6
HET 40U A 502 29
HETNAM GOL GLYCEROL
HETNAM 40U N-{(2R)-1-[(4S)-4-(4-CHLOROPHENYL)-4-HYDROXY-3,3-
HETNAM 2 40U DIMETHYLPIPERIDIN-1-YL]-3-METHYL-1-OXOBUTAN-2-YL}-2-
HETNAM 3 40U CYCLOPROPYLACETAMIDE
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 2 GOL C3 H8 O3
FORMUL 3 40U C23 H33 CL N2 O3
FORMUL 4 HOH *68(H2 O)
HELIX 1 AA1 THR A 144 PHE A 162 1 19
HELIX 2 AA2 LYS A 198 SER A 208 1 11
HELIX 3 AA3 GLY A 233 SER A 238 5 6
HELIX 4 AA4 LEU A 239 ILE A 261 1 23
HELIX 5 AA5 ILE A 261 ASP A 266 1 6
HELIX 6 AA6 PRO A 268 THR A 290 1 23
HELIX 7 AA7 GLU A 321 LEU A 333 1 13
HELIX 8 AA8 HIS A 336 PHE A 349 1 14
HELIX 9 AA9 GLN A 358 ARG A 381 1 24
HELIX 10 AB1 GLN A 383 ARG A 387 5 5
HELIX 11 AB2 PHE A 388 HIS A 418 1 31
HELIX 12 AB3 THR A 422 PHE A 429 1 8
SHEET 1 AA1 5 VAL A 222 TYR A 225 0
SHEET 2 AA1 5 VAL A 211 ARG A 216 -1 N LEU A 213 O TYR A 225
SHEET 3 AA1 5 LEU A 304 LEU A 308 -1 O CYS A 307 N SER A 212
SHEET 4 AA1 5 THR A 298 CYS A 301 -1 N TRP A 299 O TYR A 306
SHEET 5 AA1 5 PHE A 292 ASN A 293 -1 N ASN A 293 O THR A 298
SITE 1 AC1 8 THR A 161 ASP A 163 PHE A 166 TYR A 249
SITE 2 AC1 8 MET A 250 GLY A 253 ARG A 287 HOH A 664
SITE 1 AC2 11 VAL A 211 MET A 243 GLN A 285 PHE A 288
SITE 2 AC2 11 TRP A 299 TYR A 306 MET A 323 HIS A 407
SITE 3 AC2 11 PHE A 420 HOH A 624 HOH A 656
CRYST1 91.476 91.476 85.564 90.00 90.00 90.00 P 43 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010932 0.000000 0.000000 0.00000
SCALE2 0.000000 0.010932 0.000000 0.00000
SCALE3 0.000000 0.000000 0.011687 0.00000